pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-127 |
Genomic Coordinates | chr14: 100882979 - 100883075 |
Description | Homo sapiens miR-127 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-127-5p | ||||||
Sequence | 23| CUGAAGCUCAGAGGGCUCUGAU |44 | ||||||
Evidence | Experimental | ||||||
Experiments | Cloned | DRVs in miRNA |
|
||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PCLO | ||||||||||||||||||||
Synonyms | ACZ, PCH3 | ||||||||||||||||||||
Description | piccolo presynaptic cytomatrix protein | ||||||||||||||||||||
Transcript | NM_033026 | ||||||||||||||||||||
Other Transcripts | NM_014510 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PCLO | |||||||||||||||||||||
3'UTR of PCLO (miRNA target sites are highlighted) |
>PCLO|NM_033026|3'UTR 1 AGAAACATGTCTTCTCAGGGTATAGAAACTGCTCTAAATAGCCTCACATCAAGACTATAGTTGAATACTATTGTACAAAG 81 CTAAGTTTTGAGAGGCAAACATAAGAGTGGGAACAACAAGCAAAAACATACTTAAGACCTTGTACATTTATTGTTGTGGA 161 TCACACAAAGATATTCAACTGAAAAAGTTCACATACTGAAAACAAGAAGAATGGAGTTCTGAGACCTTGAATTTCCCATG 241 GCTGTGAAGAGAAACTGTGAAACAAATTTTGATTACTTAAGACAATAATCTTTGAGTAGAGTTGAGCTATAGCTTAAGAC 321 AGGCTCAAAGATTAATGTGGTTTTCATGCAGCACAAAGGTAATTCTTTATGCAAAGGAGCCTTGGTTGAAAGGAAAGGAC 401 TGATGTAACAAATCTCAGTTTTCAAAACTTCAAAAATCTTCCTTCATCGTCTTCTATTCAGACAACTTGCTGCTTTCAGA 481 TTCTGACATAAGATATACCTACAGTATGTGTCCAGGGCTGGAAGTGAGGTGGCTGTGTTCTTAGGGAAAATGGAAGAGGA 561 GATGTAGAAATTGTGGCTTTCAGGCCATATTTTACCAGTTTTCTCTGTGTCTAAATGTTACAAGCATATACAACACTGAC 641 TTTGGAATCCATGTGGTAAAAGCACATTTGTTTCTGTATCATTTGAAACAAGGTAGAGTGAAGATAATACTCAGTAGAAA 721 TAAAATTGAATTTATCTAGAAATAAAACTATGACTGGCTAACAAAGAAGAATGTTGCCCCATAAAATATTGGAATTTTGG 801 TTGAAACCATCAAAATCTTCATAATTTACCATTAAGCCAAGACATCTTCAGTCTATGTACCAAAGGACCTAGAGTAAACT 881 GATATGTTCTAGGAAGCATGATAACTTACTCTTTGTGAAACTGCAAATAAATGTATTATCCTGCACATTTCCTTTCTGTT 961 GAGCGATGCATTGACAGAGAAAGAAAATTCTTTCTCTGGCAAACAAACCATATTAATCTTGTGACATTGATTAATTAAAT 1041 GGATCCTCATTTCATAATATTTTATGCTTTTTTCCTTAATGACTTAATTCATTTACTGATTGTATCATGAAAACATGACA 1121 CTAAACTCGAGTTCTCTCTAGTGCTCTATTTTCTTACTTTAGTGACAGTATCACAGTGATCAAGTTCATCAATGTTGGGA 1201 AAATATGTGAAAAGTCAACATTTACCTGAGATTAAAATATACTTTGAGCTATTTTAATAATAATGAATAAAACAACTAAT 1281 GTCCAAGTCTTAAAATGAAGCACCCTCTTCTCTATCAGCATTATTAATTAAGGAAGTAACGTGAAGTTGTGGAAAAAACA 1361 CTCAGCAGGGAATAAAAGCCTGTCTTCTGGTCTTAGTTCTACCACTGACTGTGTCACTTTGCACATGTCACTTACACTCA 1441 CTTTACCCCAGTTTTCTTATCTATAGGATAAAAACAATTATATATTCTTAACCTTCCAAATGAGATGTTGTGATGATAAA 1521 TCAATGATCCATGAAAGATGAAAGCACATTTCCAAATATAGTTTTATACACAGAAGTGAGGAATAATTATTACATATCTT 1601 TTTAATTCTCAAATTTTATATGTGAAAAACATCATCTAAACCAATGGCAAGGATTGACATGGATAAAAGCAGTAAATTAG 1681 CCACAAAACTTATTTTTTATTTAAAATATAAACTTTAACCTGACTAAAGGTGAAGAATTACATGAAAATGCAAATTTTGC 1761 TATCCCAAATTAAATGAATAATGCTGGTCTTACCCTAGTCCTATATTCCACCCAAAAGAAATAAATCAAATTGCTTCTCA 1841 GAGCATTCTGAGCTTAAAACCTGCTGCTTTATTTAAGGGTGAAGTGTTAGTGGAATTAGAGAAAACCAACTCTAGATATT 1921 GGTTGGATATTGAATTTTCTCATTTTTAAAGAAAAAATGCTCTAAATTTGAGAGGACTGTAAAGCACTAAAAATAAGAGA 2001 ATTTCTAATATATCCCAGGATATATATATATATATATGACTTCAGAATACAAATTCGATCTTCCCCAAACTGAGAAAGAT 2081 AACCATAACTTTTCTTCCCTCTATTTTTTAATCCCCCTCCACTGACAATACAATGTCATTTACCATTGACATTGCTCTCA 2161 AATGAGCATGGGAGAGTGGAATCATCAAAGACATTATATTGCTAGTATTTTATTTTTAGAAACTATTAGATCTGCTGATG 2241 GTTGCCATGGATATTTCCAGCAGAAGCTAGCACTTGAAGAAGCCTATAATCATCACTCATAATTGGGGAAGAAAAGGTCC 2321 AAGGAGATCTCCTTCTGACATAAAAAGGCTCTGGTATTTGCCCTTAAAAGAAAACCCTGACTCATCTCTGATCCTCTTTT 2401 GCAGCCACTCATATCCATAGGTATGCATGAGAGTTTGTATGACCAGTTAGCTTTCTTCATTCCAGTTGCAATTTCTTTTA 2481 GAATAATATAAATGGAGGGATCACCAAAACAAAGATTATCTCTTTGGTAGCTATTTAACCTGAAAGCGTAGGAGTCTTTC 2561 CATTATAGAAGCCCCTCCGTTCCAAGGAACTAGCGATGGGGCTAGGTCAATCAGCAGAGTTGACAACAGGGCTTCTTTTT 2641 GTGCACCAGCATTCCCCTTCAGAGAGCATAAGATCCTGCCAGTGTGCCAAGTTTGCAGCTGACCAAACTTCTAGGTTGTA 2721 CTGGAATTATTCTATGCAACACTGATCCTTATATGAATGCGTTTCTTCTGAATGATGTTGACTACCCTTCTTACAACAAA 2801 ACTGTTTCTTTTTTATTGCAAATAGGGCTCTTGGTGTTTTTTACTTTTTTGTACATATCACAGTACATGGTTTTTCACTC 2881 TTTAGTTTATTTCATTTTATTGGAATTAACTTTTTTTTATTCTAATACTGACAGAGTTTGTAATCTCTATATAATACGTA 2961 ATTACTCCAATTACAGCACTTTTACCTTGAAGAGCATCTCAGTTTTTCCCACAATTTCATTGAGTCATCAGAGACTGATG 3041 TTGCTTCTTGGTTTCAAATTTGGTCCTAAAGAAACTTTCGGCTGTAGAAACAAAAGCACAGAGTGAATTTTTTACAAAAG 3121 ACAGGGAATATAGAATAGTCATTACAGACACAAATAACCCTAGTAGCACGAAGTTGGTGTTTTCTCTGTTTTTACTTAAG 3201 ATTAAGAAGATTTTTGGTGACTCTGAACTCTTTATTTATATTTCAGTTTAAAATATCAAGACTAAGGGGCATCAGTTATC 3281 TTTACTCTTTAATATTGCCCATATTTTAATAAATTACACTAATTAAACGCATATTTTCAGCATACCAGTGGAATTAATTT 3361 TGTGGATCACACACATTTAAATAGTCATATTGTGGGAATATTATAGCTGGTAACCAGCTGATATTGATTCTTATTATAGG 3441 AATGACTGTAATGATAGTGGTGGTAGCAGTAGTGATATTAGCGGTGGTGGTGATGTGAAGTAAAATAAAAGTATATATTA 3521 TATTGTGCCCAATTTATTAGAAATTATTTGATCAATGCTTCATTTCATTAAAATATCATAAAGATGTTTATAGTATTTTT 3601 TTACTTTATTATTTAAATCATAACTAACAATATTTTTAAAAACTTATTTTCATTGCTACAATGTCAAATATTCCAAAATC 3681 AGCCAACTACAGCTATATATGTGTTATGTGTGACAGAAGTGATCTTCCTTCCCTCTTTTTGAGCTTGACATGAAAGTGAA 3761 AGAAGACTCAATGAATAATTATGAGCTATTTATTTAATAATTACTTGCCTTGGGTGTAATACAGTAATGAATGAGTGAAA 3841 CAAATATTCTCATTGAATATGATACAATGCTGTTTTCTGTATGTTTCATGTTCTATTATTAAAGGTATCCATTAGGCCAA 3921 AATTATTTAATCAAATTCTTTATCTGATAGGTAGATTGAGAGCATTTTCTTAATGCATTACCTTGTACATAAGTATACAC 4001 TTGGTAAAGTAGACGAAGTTGAAATATTAATTTCATTTGGCATTTAGCATGTGAATATGATTATTGTTTGATTGTGTCTG 4081 TATATTTGTTTGGTGACGTGCTCAGGTGCTCCCACTACTGATTAATGTGTGTGCTAATATCCTAAAAACACATATGAGGT 4161 TTAAGAAAAAATTTTCTTGTCTGAAAACATAAACATCTTAATAAAACTGATTTTGAAATAAAAACTAAAGTACTTGAAGA 4241 TATGTCTTGTTTCTAACTATATGTTGCATGCCATGTTGGTGATTTGCTAATGTGTTTTTTTGTTTGTTTGTTTTACCCAA 4321 ATCCCTTTGGAAAATCTAATGGACAAATGCAAATTCTTGGACTAAGGACTGTATAAATTGACCTGAAAATACATGAGAGT 4401 TGCATTTAAAAAAAAATGCTTGTAAATCCGTCTTGAGTTTTACTCTATGTAAAAATATGTCTTGGTTTTGTGATTGTATA 4481 CAAGATGTATCTTGATAACTTATGTAAACTGTGCCGTATAAAGGCTGTTGCCTCAGCCTTACTAATAAATACTGAAAATA 4561 TCACCTTTGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
113 hsa-miR-127-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT380928 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT439324 | USP34 | ubiquitin specific peptidase 34 | 1 | 1 | ||||||||
MIRT439333 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT439379 | TTC37 | tetratricopeptide repeat domain 37 | 1 | 1 | ||||||||
MIRT439445 | TMEM116 | transmembrane protein 116 | 1 | 1 | ||||||||
MIRT439498 | SYNJ2 | synaptojanin 2 | 1 | 1 | ||||||||
MIRT439525 | STBD1 | starch binding domain 1 | 1 | 1 | ||||||||
MIRT439562 | SORL1 | sortilin related receptor 1 | 1 | 1 | ||||||||
MIRT439660 | SF3B1 | splicing factor 3b subunit 1 | 1 | 1 | ||||||||
MIRT439749 | ROGDI | rogdi homolog | 1 | 1 | ||||||||
MIRT439836 | RAB3B | RAB3B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT439923 | PPL | periplakin | 1 | 1 | ||||||||
MIRT439963 | PKD1 | polycystin 1, transient receptor potential channel interacting | 1 | 1 | ||||||||
MIRT439985 | PHKG2 | phosphorylase kinase catalytic subunit gamma 2 | 1 | 1 | ||||||||
MIRT440029 | PCLO | piccolo presynaptic cytomatrix protein | 1 | 1 | ||||||||
MIRT440179 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440183 | MTRNR2L4 | MT-RNR2-like 4 | 1 | 1 | ||||||||
MIRT440184 | MTRNR2L6 | MT-RNR2-like 6 | 1 | 1 | ||||||||
MIRT440194 | MTRNR2L1 | MT-RNR2-like 1 | 1 | 1 | ||||||||
MIRT440269 | MBP | myelin basic protein | 1 | 1 | ||||||||
MIRT440323 | LIN7C | lin-7 homolog C, crumbs cell polarity complex component | 1 | 1 | ||||||||
MIRT440331 | LGALS8 | galectin 8 | 1 | 1 | ||||||||
MIRT440355 | KLHL29 | kelch like family member 29 | 1 | 1 | ||||||||
MIRT440397 | KDM6B | lysine demethylase 6B | 1 | 1 | ||||||||
MIRT440411 | KAT2B | lysine acetyltransferase 2B | 1 | 1 | ||||||||
MIRT440424 | ITCH | itchy E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT440651 | FBXO7 | F-box protein 7 | 1 | 1 | ||||||||
MIRT440773 | DST | dystonin | 1 | 1 | ||||||||
MIRT440824 | DGKD | diacylglycerol kinase delta | 1 | 1 | ||||||||
MIRT440914 | COPA | coatomer protein complex subunit alpha | 1 | 1 | ||||||||
MIRT441118 | BBS4 | Bardet-Biedl syndrome 4 | 1 | 1 | ||||||||
MIRT441153 | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 1 | 1 | ||||||||
MIRT441193 | ARID1A | AT-rich interaction domain 1A | 1 | 1 | ||||||||
MIRT441260 | ADM | adrenomedullin | 1 | 1 | ||||||||
MIRT441282 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT441306 | ABHD2 | abhydrolase domain containing 2 | 1 | 1 | ||||||||
MIRT441860 | TEX35 | testis expressed 35 | 2 | 2 | ||||||||
MIRT442190 | CCDC132 | VPS50, EARP/GARPII complex subunit | 2 | 2 | ||||||||
MIRT442886 | RHCG | Rh family C glycoprotein | 2 | 2 | ||||||||
MIRT444158 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444506 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444770 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT445830 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445850 | LRRC1 | leucine rich repeat containing 1 | 2 | 2 | ||||||||
MIRT445863 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446161 | C8A | complement C8 alpha chain | 2 | 2 | ||||||||
MIRT447117 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447990 | CDX1 | caudal type homeobox 1 | 2 | 2 | ||||||||
MIRT449032 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 2 | 2 | ||||||||
MIRT449295 | SMIM19 | small integral membrane protein 19 | 2 | 2 | ||||||||
MIRT449541 | PCDH9 | protocadherin 9 | 2 | 2 | ||||||||
MIRT449579 | ZNF510 | zinc finger protein 510 | 2 | 2 | ||||||||
MIRT450062 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450437 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 2 | ||||||||
MIRT450449 | ZDHHC2 | zinc finger DHHC-type containing 2 | 2 | 2 | ||||||||
MIRT450695 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT453654 | RAB6C | RAB6C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT463771 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT468425 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468843 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT475594 | HMGB2 | high mobility group box 2 | 4 | 4 | ||||||||
MIRT478284 | DDX19A | DEAD-box helicase 19A | 2 | 2 | ||||||||
MIRT487594 | NKD2 | naked cuticle homolog 2 | 2 | 4 | ||||||||
MIRT493440 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 6 | ||||||||
MIRT496169 | RPL35A | ribosomal protein L35a | 2 | 4 | ||||||||
MIRT497566 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT497917 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498331 | PRELID2 | PRELI domain containing 2 | 2 | 2 | ||||||||
MIRT498369 | KLHL11 | kelch like family member 11 | 2 | 2 | ||||||||
MIRT498856 | LITAF | lipopolysaccharide induced TNF factor | 2 | 2 | ||||||||
MIRT505640 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT506128 | PLRG1 | pleiotropic regulator 1 | 2 | 4 | ||||||||
MIRT512242 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 4 | ||||||||
MIRT512489 | ARID2 | AT-rich interaction domain 2 | 2 | 2 | ||||||||
MIRT525251 | RNF213 | ring finger protein 213 | 2 | 2 | ||||||||
MIRT530197 | ALX1 | ALX homeobox 1 | 2 | 4 | ||||||||
MIRT530551 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT534048 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT537508 | FAM105A | family with sequence similarity 105 member A | 2 | 2 | ||||||||
MIRT543005 | CRK | CRK proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT543814 | SNX10 | sorting nexin 10 | 2 | 2 | ||||||||
MIRT549303 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT549407 | ADIPOR2 | adiponectin receptor 2 | 2 | 4 | ||||||||
MIRT550547 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT554319 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 2 | ||||||||
MIRT554515 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT559603 | AMOT | angiomotin | 2 | 2 | ||||||||
MIRT564844 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT566125 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 2 | 2 | ||||||||
MIRT567484 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT576521 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT633635 | CASC5 | kinetochore scaffold 1 | 2 | 2 | ||||||||
MIRT639325 | C9orf41 | carnosine N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT643174 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT651214 | ZNF225 | zinc finger protein 225 | 2 | 2 | ||||||||
MIRT653039 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT653042 | STOX2 | storkhead box 2 | 2 | 2 | ||||||||
MIRT658769 | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | 2 | 2 | ||||||||
MIRT666728 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT681223 | DUSP19 | dual specificity phosphatase 19 | 2 | 2 | ||||||||
MIRT685562 | SRD5A3 | steroid 5 alpha-reductase 3 | 2 | 2 | ||||||||
MIRT687434 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT688439 | DNAJC3 | DnaJ heat shock protein family (Hsp40) member C3 | 2 | 2 | ||||||||
MIRT692707 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT700552 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT704955 | CBX2 | chromobox 2 | 2 | 2 | ||||||||
MIRT714524 | ALKBH3 | alkB homolog 3, alpha-ketoglutaratedependent dioxygenase | 2 | 2 | ||||||||
MIRT716225 | DGKI | diacylglycerol kinase iota | 2 | 2 | ||||||||
MIRT717953 | MIA3 | MIA family member 3, ER export factor | 2 | 2 | ||||||||
MIRT719902 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT732044 | BLVRB | biliverdin reductase B | 3 | 1 | ||||||||
MIRT733622 | SNX5 | sorting nexin 5 | 3 | 0 | ||||||||
MIRT737210 | CXCR4 | C-X-C motif chemokine receptor 4 | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|